New Diagnostic Test Hopes to Improve Prostate Cancer Screening
A new diagnostic test developed by Nanostics Inc could dramatically help men with screening for prostate cance...
Source: vocm.com
📰 Nanostics Inc News
Nanostics Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nanostics Inc. Real-time updates on events, politics, business and more.
Global EV-Based Liquid Biopsy Market Research Report 2023:
Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The
United States Mursla Bio Thermo Fisher Scientific Inc Ev Isolation Techniques Utilizing Microfluidic Technology Lonza Group Nanostics Inc
Source: globenewswire.com
Global EV-Based Liquid Biopsy Market Research Report 2023-2032 Featuring Abcam, Bio-Techne, Horiba, Qiagen, Thermo Fisher Scientific, Malvern Panalytical, Lonza, Revvity, Takara Bio, & Norgen Biotek
/PRNewswire/ -- The "Global EV-Based Liquid Biopsy Market - A Global and Regional Analysis: Focus on Offering, Workflow, Sample Type, End User, Technology,...
Source: prnewswire.com
Nanostics Launches ClarityDX Prostate Test in Alberta to Significantly Improve Prostate Cancer Screening
/PRNewswire/ - Nanostics is thrilled to announce the availability of the ClarityDX Prostate test at its newly accredited clinical lab in Edmonton, Alberta....
Johnd Lewis Wendy Beauchesne Malcolm Bruce University Of Alberta Alberta Prostate Cancer Research Initiative Alberta Cancer Foundation
Source: prnewswire.com
EV-based Liquid Biopsy Market worth $349.19 Million by 2031 - Exclusive Report by InsightAce Analytic
/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global EV-based Liquid Biopsy Market Size, Share &...
Source: prnewswire.com
Nanostics Announces New Medical Laboratory Director Todd McMullen
/PRNewswire/ - Nanostics Inc., a precision health company developing diagnostic tests with its ClarityDX® platform technology, announced today the appointment...
John Lewis Todd Mcmullen Todd Mcmullen As Nanostic Medical Laboratory Director University Of Toronto Nanostics Inc Laboratory Director
Source: prnewswire.com
Nanostics Receives CE Mark for its ClarityDX Prostate® Test to Detect Clinically Significant Prostate Cancer
Nanostics biomarker and machine learning-powered test, ClarityDX Prostate®, received a CE-IVD Mark. A CE-IVD Mark is required for all in vitro diagnostic...
Source: prnewswire.com
Nanostics Receives CE Mark for its ClarityDX Prostate Test to Detect Clinically Significant Prostate Cancer
Nanostics' biomarker and machine learning-powered test, ClarityDX Prostate, received a CE-IVD Mark.A CE-IVD Mark is required for all in vitro diagnostic (IVD) devices to be placed in the EEA
Source: finanznachrichten.de